6 Pharmaceuticals Stocks to Buy Now

6 Pharmaceuticals Stocks to Buy Now

The grades of 6 Pharmaceuticals stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

This week, Horizon Pharma plc (HZNP) pushes up from a C to a B rating. Horizon Pharma plc is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company also gets A’s in sales growth and free cash flow. For more information, get Portfolio Grader’s complete analysis of HZNP stock.

This is a strong week for Assembly Biosciences, Inc. (ASMB). The company’s rating climbs to B from the previous week’s C. For more information, get Portfolio Grader’s complete analysis of ASMB stock.

Aratana Therapeutics, Inc. (PETX) is seeing ratings go up from a C last week to a B this week. The company also gets A’s in sales growth, earnings revisions, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of PETX stock.

Corcept Therapeutics Incorporated. (CORT) improves from a B to a A rating this week. Corcept Therapeutics Incorporated. engages in the discovery, development, and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders. The company also gets A’s in sales growth and earnings revisions. For more information, get Portfolio Grader’s complete analysis of CORT stock.

This week, ContraVir Pharmaceuticals, Inc.’s (CTRV) ratings are up from a C last week to a B. For more information, get Portfolio Grader’s complete analysis of CTRV stock.

Repros Therapeutics Inc. (RPRX) earns a B this week, jumping up from last week’s grade of C. Repros Therapeutics Inc. is a development stage biopharmaceutical company focusing on the development of oral small molecule drugs for major unmet medical needs. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of RPRX stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2016/11/6-pharmaceuticals-stocks-to-buy-now-5/.

©2020 InvestorPlace Media, LLC